Last updated: 2026-09-16 09:45:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CryoPort, Inc. (CYRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.37, with a market capitalisation of $808.36M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.61 to $17.20. This page covers its latest market performance, valuation, price trends and company information.
$808.36M | |
$16.24 | |
$86.30 | |
$1.03 | |
$16.31 | |
275.00 | |
627.01K | |
-- | |
$17.20 | |
$7.61 | |
-- | |
-- |
CryoPort, Inc. (CYRX) is trading at $16.37 in pre-market trading as of 2026-09-16 09:35:00, up 0.39% ($0.06) from the previous close of $16.31
Pre-market trading shows how investors are pricing CYRX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, CryoPort, Inc. (CYRX) moved from $15.81 to $16.37, representing a gain of 3.56% ($0.56).
The stock traded between $14.59 and $16.43 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 499.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 91.4%
CYRX is currently trading at $16.37, placing it 91.4% of the way from its 52-week low of $7.61 to its 52-week high of $17.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 738 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CryoPort, Inc. (CYRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.